[Recent results in the field of porphyria].

Suppr

超能文献

作者信息

SCHMID R, SCHWARTZ S, WATSON C J

出版信息

Acta Haematol. 1953 Sep;10(3):150-64. doi: 10.1159/000204420.

DOI:10.1159/000204420

PMID:13104087

Abstract

摘要

相似文献

[Recent results in the field of porphyria].

Acta Haematol. 1953 Sep;10(3):150-64. doi: 10.1159/000204420.

[Treatment of the porphyrias].

Nihon Rinsho. 1995 Jun;53(6):1456-62.

[Treatment of acute porphyrias. The importance of follow-up of patients and carriers].

Orv Hetil. 2003 May 11;144(19):933-8.

Dual porphyrias revisited.

Exp Dermatol. 2006 Sep;15(9):685-91. doi: 10.1111/j.1600-0625.2006.00464.x.

The cutaneous porphyrias.

Dermatol Clin. 2014 Jul;32(3):369-84, ix. doi: 10.1016/j.det.2014.03.001. Epub 2014 May 5.

Molecular characterization of porphyrias in Italy: a diagnostic flow-chart.

Cell Mol Biol (Noisy-le-grand). 2002 Dec;48(8):867-76.

The porphyrias.

Diabete Metab. 1979 Dec;5(4):323-36.

[Diagnosis and therapy of hepatic porphyria].

Acta Med Austriaca. 1990;17(5):94-9.

The porphyrias: advances in diagnosis and treatment.

Hematology Am Soc Hematol Educ Program. 2012;2012:19-27. doi: 10.1182/asheducation-2012.1.19.

[Acute hepatic porphyria and its neurological syndrome].

Schweiz Med Wochenschr. 1996 Jan 9;126(1-2):6-14.

引用本文的文献

[Porphyria cutanea tarda. III. The presence of porphyrin in the organs, body fluids and excretions (except urine)].

Arch Klin Exp Dermatol. 1960;210:252-68.

[On the pathogenesis of porphyria cutanea tarda].

Arch Klin Exp Dermatol. 1961;212:467-94. doi: 10.1007/BF00483030.

[The liver and porphyrine. I. Quantitative determination of porphyrins in the human liver].

Klin Wochenschr. 1961 Mar 15;39:298-302. doi: 10.1007/BF01482739.

[Porphyria cutanea tarda. I. General observations & clinical aspects].

Arch Klin Exp Dermatol. 1959;208(3):223-59. doi: 10.1007/BF00482815.

[Cutaneous form of hepatic porphyria and porphyrin excretion in the urine].

Arch Klin Exp Dermatol. 1958;207(6):554-75.

[Clinical aspects of porphyria].

Dtsch Z Nervenheilkd. 1955;173(4):359-76.

The effects of 2,2-diethylallylacetamide on hepatic cytochromes in rats and in vitro.

Arch Toxicol. 1979 Jun 8;42(2):137-46. doi: 10.1007/BF00316493.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Recent results in the field of porphyria].

Acta Haematol. 1953 Sep;10(3):150-64. doi: 10.1159/000204420.

[Treatment of the porphyrias].

Nihon Rinsho. 1995 Jun;53(6):1456-62.

[Treatment of acute porphyrias. The importance of follow-up of patients and carriers].

Orv Hetil. 2003 May 11;144(19):933-8.

Dual porphyrias revisited.

Exp Dermatol. 2006 Sep;15(9):685-91. doi: 10.1111/j.1600-0625.2006.00464.x.

The cutaneous porphyrias.

Dermatol Clin. 2014 Jul;32(3):369-84, ix. doi: 10.1016/j.det.2014.03.001. Epub 2014 May 5.

Molecular characterization of porphyrias in Italy: a diagnostic flow-chart.

Cell Mol Biol (Noisy-le-grand). 2002 Dec;48(8):867-76.

The porphyrias.

Diabete Metab. 1979 Dec;5(4):323-36.

[Diagnosis and therapy of hepatic porphyria].

Acta Med Austriaca. 1990;17(5):94-9.

The porphyrias: advances in diagnosis and treatment.

Hematology Am Soc Hematol Educ Program. 2012;2012:19-27. doi: 10.1182/asheducation-2012.1.19.

[Acute hepatic porphyria and its neurological syndrome].

Schweiz Med Wochenschr. 1996 Jan 9;126(1-2):6-14.

引用本文的文献

[Porphyria cutanea tarda. III. The presence of porphyrin in the organs, body fluids and excretions (except urine)].

Arch Klin Exp Dermatol. 1960;210:252-68.

[On the pathogenesis of porphyria cutanea tarda].

Arch Klin Exp Dermatol. 1961;212:467-94. doi: 10.1007/BF00483030.

[The liver and porphyrine. I. Quantitative determination of porphyrins in the human liver].

Klin Wochenschr. 1961 Mar 15;39:298-302. doi: 10.1007/BF01482739.

[Porphyria cutanea tarda. I. General observations & clinical aspects].

Arch Klin Exp Dermatol. 1959;208(3):223-59. doi: 10.1007/BF00482815.

[Cutaneous form of hepatic porphyria and porphyrin excretion in the urine].

Arch Klin Exp Dermatol. 1958;207(6):554-75.

[Clinical aspects of porphyria].

Dtsch Z Nervenheilkd. 1955;173(4):359-76.

The effects of 2,2-diethylallylacetamide on hepatic cytochromes in rats and in vitro.

Arch Toxicol. 1979 Jun 8;42(2):137-46. doi: 10.1007/BF00316493.